Ayurcann Holdings Corp

OTCQB:AYURF USA Drug Manufacturers - Specialty & Generic
Market Cap
$3.41 Million
Market Cap Rank
#37958 Global
#12360 in USA
Share Price
$0.02
Change (1 day)
+0.00%
52-Week Range
$0.02 - $0.02
All Time High
$0.19
About

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPL… Read more

Ayurcann Holdings Corp (AYURF) - Total Liabilities

Latest total liabilities as of September 2025: $15.44 Million USD

Based on the latest financial reports, Ayurcann Holdings Corp (AYURF) has total liabilities worth $15.44 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ayurcann Holdings Corp - Total Liabilities Trend (2018–2025)

This chart illustrates how Ayurcann Holdings Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Ayurcann Holdings Corp Competitors by Total Liabilities

The table below lists competitors of Ayurcann Holdings Corp ranked by their total liabilities.

Company Country Total Liabilities
Apollo Bancorp Inc
PINK:APLO
USA $183.52 Million
FRESNILLO (FNL.SG)
STU:FNL
Germany €1.67 Billion
Bullion Gold Resources Corp
PINK:TTEXF
USA $100.54K
Wesizwe
JSE:WEZ
South Africa ZAC30.29 Billion
Elcom International Inc
PINK:ELCO
USA $4.93 Million
Bond Resources Inc
F:5B1
Germany €1.84 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Ayurcann Holdings Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -3.81 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ayurcann Holdings Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ayurcann Holdings Corp (2018–2025)

The table below shows the annual total liabilities of Ayurcann Holdings Corp from 2018 to 2025.

Year Total Liabilities Change
2025-06-30 $15.63 Million +9.13%
2024-06-30 $14.32 Million +42.65%
2023-06-30 $10.04 Million +320.17%
2022-06-30 $2.39 Million +23.92%
2021-06-30 $1.93 Million +10449.90%
2020-06-30 $18.27K -2.19%
2019-06-30 $18.68K -50.32%
2018-06-30 $37.61K --